Magnetic Resonance Imaging in Cardiac Amyloidosis

JACC: Cardiovascular Imaging

Volumn 2, Issue 12, 2009, Pages 1378-1380

  Pennell, Dudley J ^a   Maceira, Alicia M ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b Hospital General Universitario Avda   (Spain)

Author keywords

amyloidosis; diagnosis; heart; magnetic resonance; prognosis

Indexed keywords

AMYLOID PROTEIN; GADOLINIUM; MELPHALAN;

AMYLOIDOSIS; ANGINA PECTORIS; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DOPPLER ECHOCARDIOGRAPHY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; EDITORIAL; ELECTROCARDIOGRAPHY; HEART AMYLOIDOSIS; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART TRANSPLANTATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RESTRICTIVE CARDIOMYOPATHY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC DISEASE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AMYLOIDOSIS; BIOPSY; CONTRAST MEDIA; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 71749115408     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.10.001     Document Type: Editorial

References (10)

1. Falk R.H. Diagnosis and management of the cardiac amyloidoses. Circulation 112 (2005) 2047-2060
2. Rahman J.E., Helou E.F., Gelzer-Bell R., et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 43 (2004) 410-415
3. Maceira A.M., Joshi J., Prasad S.K., et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111 (2005) 186-193
4. Ruberg F.L., Appelbaum E., Davidoff R., et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 103 (2009) 544-549
5. Vogelsberg H., Marholdt H., and Deluigi C.C. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51 (2008) 1022-1030
6. Austin B.A., Tang W.H.W., Rodriguez E.R., et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. J Am Coll Cardiol Img 2 (2009) 1369-1377
7. Kristen A.V., Perz J.B., Schonland S.O., et al. Noninvasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail 9 (2007) 617-624
8. Klein A., Hatle L.K., Taliercio C.P., et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiographic study. Circulation 83 (1991) 808-816
9. Tei C., Dujardin K.S., Hodge D.O., Kyle R.A., Tajik A.J., and Seward J.B. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 28 (1996) 658-664
10. Maceira A.M., Prasad S.K., Hawkins P.N., Roughton M., and Pennell D.J. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 10 (2008) 54-65